Langenberg, Marlies H.G.
University Medical Center Utrecht
2 papers on CoChat
Most cited papers
- Verified
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors
Meulendijks, D., Jacob, W., Martinez-Garcia, M., Taus, A., Lolkema, M. P., Voest, E. E., Langenberg, M. H. G., Fleitas Kanonnikoff, T., Cervantes, A., De Jonge, M. J., et al. (2016) · Clinical Cancer Research
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 73
- Verified
A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
de Weger, V. A., de Jonge, M., Langenberg, M. H. G., Schellens, J. H. M., Lolkema, M., Varga, A., Demers, B., Thomas, K., Hsu, K., Tuffal, G., et al. (2019) · British Journal of Cancer
Cancer-related Molecular PathwaysMelanoma and MAPK Pathways
Cited by 62
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free